<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pirogovestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Национального медико-хирургического центра им. Н.И. Пирогова</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Pirogov National Medical &amp; Surgical Center</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-8255</issn><issn pub-type="epub">2782-3628</issn><publisher><publisher-name>Национальный медико-хирургический Центр им. Н.И. Пирогова</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25881/20728255_2025_20_1_32</article-id><article-id custom-type="elpub" pub-id-type="custom">pirogovestnik-259</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ПОЛОВЫЕ РАЗЛИЧИЯ КЛИНИЧЕСКИХ И РАДИОЛОГИЧЕСКИХ ПОКАЗАТЕЛЕЙ У ПАЦИЕНТОВ C РЕМИТТИРУЮЩИМ ТИПОМ ТЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА В КУРСКОЙ ОБЛАСТИ</article-title><trans-title-group xml:lang="en"><trans-title>GENDER DIFFERENCES IN CLINICAL AND RADIOLOGICAL PARAMETERS IN PATIENTS WITH RELAPSING-REMITTING TYPE OF MULTIPLE SCLEROSIS IN THE KURSK REGION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Боломатов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bolomatov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">n-v-bolomatov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шульженко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shulzhenko</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курск</p></bio><bio xml:lang="en"><p>Kursk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Масалева</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Masaleva</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курск</p></bio><bio xml:lang="en"><p>Kursk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молчанов</surname><given-names>И. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Molchanov</surname><given-names>I. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курск</p></bio><bio xml:lang="en"><p>Kursk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Национальный медико-хирургический Центр им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov National Medical and Surgical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Курский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>03</month><year>2025</year></pub-date><volume>20</volume><issue>1</issue><fpage>32</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Боломатов Н.В., Шульженко Е.А., Масалева И.О., Молчанов И.П., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Боломатов Н.В., Шульженко Е.А., Масалева И.О., Молчанов И.П.</copyright-holder><copyright-holder xml:lang="en">Bolomatov N.V., Shulzhenko E.A., Masaleva I.O., Molchanov I.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://submit.pirogov-vestnik.ru/jour/article/view/259">https://submit.pirogov-vestnik.ru/jour/article/view/259</self-uri><abstract><p>Введение. Рассеянный склероз (РС) характеризуется особенностями течения у пациентов разных полов. Описываемые нейродегенеративный и провоспалительный фенотипы РС имеют разную представленность у мужчин и женщин. Разнообразие взглядов относительно влияния расположения, размеров очагов димиелинизации и степени инвалидизации пациентов с рассеянным склерозом обуславливает важность оценки данных параметров по гендерному признаку.Цель исследования. Анализ гендерных особенностей в расположении зон демиелинизации, связи между морфологическими и количественными особенностями очаговых изменений и инвалидизацией у больных рассеянным склерозом.Материалы и методы. Проведен проспективный разбор данных МРТ 103 пациентов (женщины – 54, мужчины – 49; средний возраст – 39±11,7) с ремиттирующе-рецидивирующим течением РС в период стойкой ремиссии, получавших амбулаторно-поликлиническую помощь в Курской областной многопрофильной клинической больнице за 2017-2024 гг. с применением критериев согласия и корреляционного анализа.Результаты. Наличие перивентрикулярных очагов демиелинизации в 72,2% случаев фиксировалось у женщин, в то время как у мужчин этот показатель составил 97,9%, различия достоверны (p&lt; 0,05). В шейном отделе демиелинизирующий процесс был более выражен у мужчин (79,6%) по сравнению с женщинами (40,7%), что является статистически значимым (p&lt; 0,05). При оценке выраженности димиелинизации в мозжечке выявлено, что у мужчин доля очагов составила 46,9%, в то время как у женщин этот показатель был равен 29,6% (p&lt; 0,05). Корреляционный анализ с использованием критерия Спирмена выявил достоверное влияние количества очагов на EDSS в мужской популяции (p&lt; 0,05). Корреляционный анализ выявил умеренную положительную связь размеров (min/max) и показателей инвалидизации связи у пациентов женского пола (ρ =0,397; p&lt; 0,05).Заключение. У мужчин очаги локализируются чаще перивентрикулярно, в мозжечке, мозолистом теле и шейном отделе спинного мозга по сравнению с женщинами, что сопоставимо со степенью инвалидизации. У женщин наблюдается меньшая выраженность димиелинизирующего процесса и более благоприятный прогноз по EDSS.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Multiple sclerosis (MS) is characterized by its course in patients of different genders. The described neurodegenerative and proinflammatory phenotypes of MS have different representation in men and women. The diversity of views on the influence of the location, size of demyelination foci and the degree of disability in patients with multiple sclerosis determines the importance of assessing these parameters by gender.The aim of the study was to analyze gender characteristics in the location of demyelination zones, the relationship between morphological and quantitative features of focal changes and disability in patients with multiple sclerosis.Materials and methods. A prospective analysis of magnetic resonance imaging data was performed in 103 patients (women – 54, men – 49; average age – 39±11.7) with relapsing-remitting multiple sclerosis during the period of persistent remission, who received outpatient care at the Kursk Regional Multidisciplinary Clinical Hospital in 2017-2024 using the consent criteria and correlation analysis.Results. The presence of periventricular foci of demyelination in 72.2% of cases was recorded in women, while in men this figure was 97.9%, the differences are significant (p&lt; 0.05). In the corpus callosum, demyelination foci were more often observed in men than in women – 46.2% versus 65.3% (p&lt; 0.05). In the cervical spine, the demyelinating process was more pronounced in men (79.6%) compared to women (40.7%), which is statistically significant (p&lt; 0.05). When assessing the severity of demyelination in the cerebellum, it was found that in men the proportion of foci was 46.9%, while in women this figure was 29.6% (p&lt; 0.05). Correlation analysis using the Spearman criterion revealed a reliable effect of the number of foci on EDSS in the male population (p&lt; 0.05). Correlation analysis revealed a moderate positive relationship between the sizes (min/max) and the disability indices of the connection in female patients (ρ = 0.397; p&lt; 0.05).Conclusion. In men, foci are localized more often periventricularly, in the cerebellum, corpus callosum and cervical spinal cord compared to women, which is comparable with the degree of disability. Women have a lesser degree of demyelinating process and a more favorable prognosis according to EDSS.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>МРТ</kwd><kwd>нейрорадиология</kwd><kwd>пол</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>MRI</kwd><kwd>neuroradiology</kwd><kwd>gender</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hauser SL, Cree BAC. Treatment of Multiple Sclerosis: A Review. Am J Med. 2020; 133(12): 1380-1390.e2. doi: 10.1016/j.amjmed.2020.05.049.</mixed-citation><mixed-citation xml:lang="en">Hauser SL, Cree BAC. Treatment of Multiple Sclerosis: A Review. Am J Med. 2020; 133(12): 1380-1390.e2. doi: 10.1016/j.amjmed.2020.05.049.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Faissner S, Plemel JR, Gold R, et al. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov. 2019; 18(12): 905-922. doi: 10.1038/s41573-019-0035-2.</mixed-citation><mixed-citation xml:lang="en">Faissner S, Plemel JR, Gold R, et al. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov. 2019; 18(12): 905-922. doi: 10.1038/s41573-019-0035-2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Correale J, Gaitán MI, Ysrraelit MC, et al. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017; 140(3): 527-546. doi: 10.1093/brain/aww258.</mixed-citation><mixed-citation xml:lang="en">Correale J, Gaitán MI, Ysrraelit MC, et al. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017; 140(3): 527-546. doi: 10.1093/brain/aww258.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wingerchuk DM, Carter JL. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc. 2014; 89(2): 225-40. doi: 10.1016/j.mayocp.2013.11.002.</mixed-citation><mixed-citation xml:lang="en">Wingerchuk DM, Carter JL. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc. 2014; 89(2): 225-40. doi: 10.1016/j.mayocp.2013.11.002.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fujita S, Yokoyama K, Hagiwara A, et al. 3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions. AJNR Am J Neuroradiol. 2021; 42(3): 471-478. doi: 10.3174/ajnr.A6930.</mixed-citation><mixed-citation xml:lang="en">Fujita S, Yokoyama K, Hagiwara A, et al. 3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions. AJNR Am J Neuroradiol. 2021; 42(3): 471-478. doi: 10.3174/ajnr.A6930.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ward M, Goldman MD. Epidemiology and Pathophysiology of Multiple Sclerosis. Continuum (Minneap Minn). 2022; 28(4): 988-1005. doi: 10.1212/CON.0000000000001136.</mixed-citation><mixed-citation xml:lang="en">Ward M, Goldman MD. Epidemiology and Pathophysiology of Multiple Sclerosis. Continuum (Minneap Minn). 2022; 28(4): 988-1005. doi: 10.1212/CON.0000000000001136.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hartmann A, Noro F, Bahia PRV, et al. The clinical-radiological paradox in multiple sclerosis: myth or truth? O paradoxo clínico radiológico na esclerose múltipla: mito ou verdade? Arq Neuropsiquiatr. 2023; 81(1): 55-61. doi: 10.1055/s-0042-1758457.</mixed-citation><mixed-citation xml:lang="en">Hartmann A, Noro F, Bahia PRV, et al. The clinical-radiological paradox in multiple sclerosis: myth or truth? O paradoxo clínico radiológico na esclerose múltipla: mito ou verdade? Arq Neuropsiquiatr. 2023; 81(1): 55-61. doi: 10.1055/s-0042-1758457.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen AB, Neema M, Arora A, et al. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012; 22(2): 122-128. doi: 10.1111/j.1552-6569.20-11.00589.x.</mixed-citation><mixed-citation xml:lang="en">Cohen AB, Neema M, Arora A, et al. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012; 22(2): 122-128. doi: 10.1111/j.1552-6569.20-11.00589.x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zeydan B, Kantarci OH. Impact of Age on Multiple Sclerosis Disease Activity and Progression. Curr Neurol Neurosci. 2020; 20(7): 24. doi: 10.1007/s11910-020-01046-2.</mixed-citation><mixed-citation xml:lang="en">Zeydan B, Kantarci OH. Impact of Age on Multiple Sclerosis Disease Activity and Progression. Curr Neurol Neurosci. 2020; 20(7): 24. doi: 10.1007/s11910-020-01046-2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Degraeve B, Sequeira H, Mecheri H, et al. Corpus callosum damage to account for cognitive, affective, and social-cognitive dysfunctions in multiple sclerosis: A model of callosal disconnection syndrome? Mult Scler. 2023; 29(2): 160-168. doi: 10.1177/13524585221091067.</mixed-citation><mixed-citation xml:lang="en">Degraeve B, Sequeira H, Mecheri H, et al. Corpus callosum damage to account for cognitive, affective, and social-cognitive dysfunctions in multiple sclerosis: A model of callosal disconnection syndrome? Mult Scler. 2023; 29(2): 160-168. doi: 10.1177/13524585221091067.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fritz NE, Edwards EM, Ye C, et al. Cerebellar Contributions to Motor and Cognitive Control in Multiple Sclerosis. Arch Phys Med Rehabil. 2022; 103(8): 1592-1599. doi: 10.1016/j.apmr.2021.12.010.</mixed-citation><mixed-citation xml:lang="en">Fritz NE, Edwards EM, Ye C, et al. Cerebellar Contributions to Motor and Cognitive Control in Multiple Sclerosis. Arch Phys Med Rehabil. 2022; 103(8): 1592-1599. doi: 10.1016/j.apmr.2021.12.010.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
